Skip to Main Content

Author Details

Heinrich Kovar
St. Anna Children's Cancer Research Institute (CCRI), Medical University Vienna
1985
137
46
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36462556High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-X<sub>L</sub> inhibition against Ewing sarcoma.Cancer Lett2023
36462556High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-X<sub>L</sub> inhibition against Ewing sarcoma.Cancer Lett2023
36115869An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.NPJ Precis Oncol2022
35455947Zooming in on Long Non-Coding RNAs in Ewing Sarcoma Pathogenesis.Cells2022
36115869An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.NPJ Precis Oncol2022
35455947Zooming in on Long Non-Coding RNAs in Ewing Sarcoma Pathogenesis.Cells2022
33419969YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells.Oncogenesis2021
33919988Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives.J Clin Med2021
33419969YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells.Oncogenesis2021
34553032Systematic review of the immunological landscape of Wilms tumors.Mol Ther Oncolytics2021
33919988Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives.J Clin Med2021
34553032Systematic review of the immunological landscape of Wilms tumors.Mol Ther Oncolytics2021
32326412The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis.Cells2020
32326412The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis.Cells2020
32881892Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma.PLoS One2020
32881892Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma.PLoS One2020
31392992EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex.Nucleic Acids Res2019
31577941ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma.Cell Rep2019
31406155Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.Cell Death Dis2019
31392992EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex.Nucleic Acids Res2019
31406155Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.Cell Death Dis2019
31577941ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma.Cell Rep2019
29414935Selective enhancer changes in osteosarcoma lung metastasis.Nat Med2018
30123424Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers.Oncotarget2018
29977059Ewing sarcoma.Nat Rev Dis Primers2018
30093639Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility.Nat Commun2018
30038364Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.Cell Death Dis2018
29414935Selective enhancer changes in osteosarcoma lung metastasis.Nat Med2018
30123424Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers.Oncotarget2018
30093639Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility.Nat Commun2018
30038364Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.Cell Death Dis2018
29977059Ewing sarcoma.Nat Rev Dis Primers2018
27191748Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model.Oncotarget2017
28691904Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts.Elife2017
28671673EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma.Oncogene2017
27191748Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model.Oncotarget2017
27760381High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.Gene2017
28062706Combinatorial Drug Screening Identifies Ewing Sarcoma-specific Sensitivities.Mol Cancer Ther2017
28148901C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells.Oncotarget2017
28134926DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma.Nat Med2017
28030800The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma.Oncotarget2017
28160567EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells.Oncotarget2017
28134926DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma.Nat Med2017
28160567EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells.Oncotarget2017
28148901C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells.Oncotarget2017
28671673EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma.Oncogene2017
28691904Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts.Elife2017
27760381High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.Gene2017
28030800The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma.Oncotarget2017
28062706Combinatorial Drug Screening Identifies Ewing Sarcoma-specific Sensitivities.Mol Cancer Ther2017
  • 1 - 50 of 274

Recommended Authors

Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 2
Ogan D Abaan
Illumina Inc.
Career Start Year 2005
Number of shared co-authors 8
Mario L Suv??
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 4
Piergiorgio Modena
S. Anna General Hospital
Career Start Year 2000
Number of shared co-authors 3
Joyce E Ohm
Roswell Park Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Agnes Viale
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 4
Qing-Rong Chen
Center for Biomedical Informatics and Information Technology
Career Start Year 1996
Number of shared co-authors 16
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 12
Brian J P Huntly
University of Cambridge
Career Start Year 1996
Number of shared co-authors 1
Yi-Mi Wu
University of Michigan Medical School ann arbor
Career Start Year 1995
Number of shared co-authors 1
Russell Bell
Huntsman Cancer Institute at the University of Utah
Career Start Year 1995
Number of shared co-authors 2
Mar??a D Odero
University of Navarra
Career Start Year 1994
Number of shared co-authors 2
Doris Steinemann
Hannover Medical School
Career Start Year 1994
Number of shared co-authors 6
Seishi Ogawa
Kyoto University
Career Start Year 1993
Number of shared co-authors 3
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1993
Number of shared co-authors 6
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 11
John Easton
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 19
Scott A Armstrong
Boston Children's Hospital
Career Start Year 1990
Number of shared co-authors 3
Dirk Geerts
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 1
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 12
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year 1989
Number of shared co-authors 5
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 1
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 2
Choh Yeung
Center for Cancer Research, National Cancer Institute
Career Start Year 1987
Number of shared co-authors 7
Peter Lichter
German Cancer Research Center (DKFZ)
Career Start Year 1986
Number of shared co-authors 16
David M Loeb
Children's Hospital at Montefiore.
Career Start Year 1986
Number of shared co-authors 11
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 1
Ching C Lau
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 32
Alex Look
Dana-Farber Cancer Institute
Career Start Year 1975
Number of shared co-authors 9

Collaborators

Maximilian Kauer
St. Anna Children's Cancer Research Institute (CCRI)
Co-authored papers 23
Peter F Ambros
Children's Cancer Research Institute, Medical University of Vienna
Co-authored papers 21
Jozef Ban
Children's Cancer Research Institute
Co-authored papers 19
Olivier Delattre
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Co-authored papers 18
Raphaela Schwentner
Children's Cancer Research Institute
Co-authored papers 18
Gunhild Jug
Children's Cancer Research Institute
Co-authored papers 17
Uta Dirksen
University Hospital Essen, West German Cancer Center
Co-authored papers 12
Eleni M Tomazou
St. Anna Children's Cancer Research Institute (CCRI)
Co-authored papers 11
Ruth Ladenstein
Children's Cancer Research Institute
Co-authored papers 11
Inge M Ambros
St. Anna Children's Cancer Research Institute
Co-authored papers 10
Jeffrey A Toretsky
Georgetown University Medical Center, Georgetown University
Co-authored papers 10
Aykut Uren
Georgetown University Medical Center
Co-authored papers 9
Piero Picci
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 9
Franck Tirode
Cancer Center of Lyon
Co-authored papers 9
Didier Surdez
Balgrist University Hospital, University of Zurich (UZH)
Co-authored papers 9
Katia Scotlandi
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 8
Elizabeth R Lawlor
Seattle Children's Research Institute
Co-authored papers 8
G??nther H S Richter
Children's Cancer Research Center
Co-authored papers 7
Enrique de Alava
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Co-authored papers 7
Richard Moriggl
Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna
Co-authored papers 7
Reinhard Windhager
Medical University of Vienna
Co-authored papers 7
Branka Radic-Sarikas
St. Anna Children's Cancer Research Institute (CCRI), Medical University of Vienna
Co-authored papers 7
Udo Kontny
Co-authored papers 7
Markus Metzler
University Hospital Erlangen
Co-authored papers 6
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 6
Ga??lle Pierron
Institut Curie Hospital
Co-authored papers 6
Jean Michon
Institut Curie
Co-authored papers 6
Thomas G P Gr??newald
German Cancer Research Center
Co-authored papers 6
Reinhard Kofler
Medical University of Innsbruck
Co-authored papers 5
Stephen L Lessnick
The Ohio State University College of Medicine
Co-authored papers 5
Release 1.2